Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Brem

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Scientific Reports|May 24, 2022
Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastomaAnahita Fathi Kazerooni, Sanjay Saxena, Erik Toorens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium MeetingNancy D Doolittle, Lauren E Abrey, W Archie Bleyer, et al.
Autophagy|July 4, 2014
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiformeMyrna R Rosenfeld, Xiaobu Ye, Jeffrey G Supko, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PETAli Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
Neuro-Oncology|January 14, 2023
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trialJohn H Sampson, Achal Singh Achrol, Manish K Aghi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2019
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective StudyStephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent GlioblastomaElizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.
Cell|December 30, 2019
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral HeterogeneityFadi Jacob, Ryan D Salinas, Daniel Y Zhang, et al.
Cell Reports|January 19, 2017
Primary Cell Culture of Live Neurosurgically Resected Aged Adult Human Brain Cells and Single Cell TranscriptomicsJennifer M Spaethling, Young-Ji Na, Jaehee Lee, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Scientific Reports|May 24, 2022
Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastomaAnahita Fathi Kazerooni, Sanjay Saxena, Erik Toorens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium MeetingNancy D Doolittle, Lauren E Abrey, W Archie Bleyer, et al.
Autophagy|July 4, 2014
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiformeMyrna R Rosenfeld, Xiaobu Ye, Jeffrey G Supko, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PETAli Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
Neuro-Oncology|January 14, 2023
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trialJohn H Sampson, Achal Singh Achrol, Manish K Aghi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2019
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective StudyStephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent GlioblastomaElizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.
Cell|December 30, 2019
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral HeterogeneityFadi Jacob, Ryan D Salinas, Daniel Y Zhang, et al.
Cell Reports|January 19, 2017
Primary Cell Culture of Live Neurosurgically Resected Aged Adult Human Brain Cells and Single Cell TranscriptomicsJennifer M Spaethling, Young-Ji Na, Jaehee Lee, et al.
Pageof 13